SR

Srinivasa Rao Chennupati

Active Director Director DIN 10738255
DIN 10738255 First appointment Aug 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivasa Rao Chennupati

Data last updated:

Srinivasa Rao Chennupati is a Director at Coastal Drugs Innovations Private Limited (since 2024). The company operates in Paper.

DIN 10738255
Primary Designation Director
Industry Paper
First Appointment 10 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Aug 20242024Active

Board colleagues of Srinivasa Rao Chennupati

Directorship timeline

Open interactive timeline →
Coastal Drugs Innovations Private Limited
Premium access

Shareholding and investment profile for Srinivasa Rao Chennupati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Rao Chennupati

Srinivasa Rao Chennupati currently holds 1 directorship: Coastal Drugs Innovations Private Limited (Director, since 10 Aug 2024).

Srinivasa Rao Chennupati was first appointed on 10 Aug 2024 as Director at Coastal Drugs Innovations Private Limited.

The current boards of Srinivasa Rao Chennupati's companies include Sreekanth Chappidi (Coastal Drugs Innovations Private Limited), Venkata Krishna Sai Suryadevara (Coastal Drugs Innovations Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available